BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25239509)

  • 21. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
    Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
    Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
    Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results.
    Stepien M; Rosniak-Bak K; Paradowski M; Misztal M; Kujawski K; Banach M; Rysz J
    Med Sci Monit; 2011 Nov; 17(11):PR13-18. PubMed ID: 22037753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women.
    Vicennati V; Genghini S; De Iasio R; Pasqui F; Pagotto U; Pasquali R
    Eur J Endocrinol; 2007 Sep; 157(3):295-301. PubMed ID: 17766711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
    dos Santos Silva CM; Barbosa FR; Lima GA; Warszawski L; Fontes R; Domingues RC; Gadelha MR
    Obesity (Silver Spring); 2011 Apr; 19(4):800-5. PubMed ID: 20559294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
    Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
    Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet determines features of the metabolic syndrome in 6- to 14-year-old children.
    Aeberli I; Spinas GA; Lehmann R; l'Allemand D; Molinari L; Zimmermann MB
    Int J Vitam Nutr Res; 2009 Jan; 79(1):14-23. PubMed ID: 19838999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin/leptin ratio and insulin resistance in pregnancy.
    Skvarca A; Tomazic M; Blagus R; Krhin B; Janez A
    J Int Med Res; 2013 Feb; 41(1):123-8. PubMed ID: 23569137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients.
    Labruna G; Pasanisi F; Nardelli C; Caso R; Vitale DF; Contaldo F; Sacchetti L
    Obesity (Silver Spring); 2011 Jul; 19(7):1492-6. PubMed ID: 21183936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
    Mastroeni SS; Mastroeni MF; Gonçalves Mde C; Debortoli G; da Silva NN; Bernal RT; Adamovski M; Veugelers PJ; Rondó PH
    Appl Physiol Nutr Metab; 2016 Jun; 41(6):659-65. PubMed ID: 27227571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.
    Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
    Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin/adiponectin ratio in patients with coronary heart disease: comparing subjects with and without metabolic syndrome.
    Hall JI; Vora N; Langworthy R; Stock S; Momin A; Sherwood RA; le Roux CW; Alaghband-Zadeh J
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):327-31. PubMed ID: 21502199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ghrelin level negatively predicts quality of life in obese women.
    Lu PH; Song YL; Hsu CH
    Psychol Health Med; 2017 Feb; 22(2):162-171. PubMed ID: 27228455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.
    de Abreu VG; Martins CJM; de Oliveira PAC; Francischetti EA
    PLoS One; 2017; 12(7):e0180947. PubMed ID: 28746378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity.
    Siejka A; Jankiewicz-Wika J; Kołomecki K; Cywiński J; Piestrzeniewicz K; Swiętosławski J; Stępień H; Komorowski J
    Cytokine; 2013 Nov; 64(2):490-3. PubMed ID: 24011638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies.
    Baratta R; Amato S; Degano C; Farina MG; Patanè G; Vigneri R; Frittitta L
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2665-71. PubMed ID: 15181039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
    Gannagé-Yared MH; Azar RR; Amm-Azar M; Khalifé S; Germanos-Haddad M; Neemtallah R; Halaby G
    Metabolism; 2005 Jul; 54(7):947-51. PubMed ID: 15988706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.